Maravai LifeSciences Inc... (MRVI)
4.73
0.19 (4.19%)
At close: Jan 15, 2025, 10:31 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | 288.94M | 883.00M | 799.24M | 284.10M | 143.14M | 123.83M |
| Cost of Revenue | 148.74M | 168.96M | 140.56M | 79.65M | 66.85M | 60.77M |
| Gross Profit | 140.20M | 714.04M | 658.68M | 204.45M | 76.29M | 63.07M |
| Operating Income | -31.65M | 574.22M | 554.64M | 67.60M | 23.99M | 16.44M |
| Interest Income | 27.73M | 2.34M | 30.26M | 30.74M | 29.96M | n/a |
| Pretax Income | 617.74M | 551.47M | 530.76M | 81.70M | -5.85M | -16.50M |
| Net Income | -119.03M | 490.66M | 469.25M | 76.89M | -5.20M | -17.73M |
| Selling & General & Admin | 151.39M | 129.26M | 100.06M | 94.25M | 48.35M | 41.19M |
| Research & Development | 17.28M | 18.37M | 15.22M | 9.30M | 3.63M | 4.50M |
| Other Expenses | 3.18M | -358.00K | 279.00K | -7.47M | 118.00K | 87.00K |
| Operating Expenses | 171.85M | 147.63M | 115.28M | 103.55M | 51.98M | 45.69M |
| Interest Expense | 45.89M | 20.41M | 30.26M | 30.74M | 29.96M | 27.40M |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 320.59M | 316.58M | 255.84M | 183.20M | 118.83M | 106.46M |
| Income Tax | 756.11M | 60.81M | 61.52M | 2.88M | -652.00K | 417.00K |
| Shares Outstanding (Basic) | 131.92M | 131.54M | 114.79M | 96.65M | 96.65M | 88.97M |
| Shares Outstanding (Diluted) | 131.92M | 255.32M | 257.80M | 96.65M | 96.65M | 88.97M |
| EPS (Basic) | -0.9 | 3.73 | 4.09 | 0.80 | -0.05 | -0.2 |
| EPS (Diluted) | -0.9 | 1.92 | 1.82 | 0.70 | -0.05 | -0.2 |
| EBITDA | 712.41M | 609.99M | 585.78M | 138.27M | 48.19M | 33.25M |
| Depreciation & Amortization | 48.78M | 38.10M | 24.75M | 25.84M | 24.08M | 22.35M |